Identification of novel PPARα/γ dual agonists by virtual screening, ADMET prediction and molecular dynamics simulations

References

• Ahmad, S., Khan, M. F., Parvez, S., Akhtar, M., & Raisuddin, S. (2016). Molecular docking reveals the potential of phthalate esters to inhibit the enzymes of the glucocorticoid biosynthesis pathway. Journal of Applied Toxicology, 37, 265–277.
   PubMed Web of Science ®Google Scholar
• Ahmad, A., Ahmad, A., Sudhakar, R., Varshney, H., Subbarao, N., Ansari, S. … Khan, A. U. (2016). Designing, synthesis and antimicrobial action of oxazoline and thiazoline derivatives of fatty acid esters. Journal of Biomolecular Structure & Dynamics, 1–20.
   Web of Science ®Google Scholar
• Barter, P. J., & Rye, K. A. (2008). Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arteriosclerosis Thrombosis & Vascular Biology, 28, 39–46.
   PubMed Web of Science ®Google Scholar
• Blessy, J. J., & Sharmila, D. J. (2015). Molecular simulation of N-acetylneuraminic acid analogs and molecular dynamics studies of cholera toxin-Neu5Gc complex. Journal of Biomolecular Structure & Dynamics, 33, 1126–1139.10.1080/07391102.2014.931825
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A. … Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. Paper presented at the SC 2006 Conference, Proceedings of the ACM/IEEE.
   Google Scholar
• Boyle, P. J., King, A. B., Olansky, L., Marchetti, A., Lau, H., Magar, R., & Martin, J. (2002). Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records. Clinical Therapeutics, 24, 378–396.10.1016/S0149-2918(02)85040-8
   PubMed Web of Science ®Google Scholar
• Carpino, Philip A., & Goodwin, Bryan. (2010). Diabetes area participation analysis: A review of companies and targets described in the 2008–2010 patent literature. Expert Opinion on Therapeutic Patents, 20, 1627–1651. doi:10.1517/13543776.2010.533171
   PubMed Web of Science ®Google Scholar
• Cheng, A., & Dixon, S. L. (2003). In silico models for the prediction of dose-dependent human hepatotoxicity. Journal of Computer-Aided Molecular Design, 17, 811–823.10.1023/B:JCAM.0000021834.50768.c6
   PubMed Web of Science ®Google Scholar
• Cheng, A., & Merz, ‡K. M. (2003). Prediction of aqueous solubility of a diverse set of compounds using quantitative structure−property relationships. Journal of Medicinal Chemistry, 46, 3572–3580.
   PubMed Web of Science ®Google Scholar
• Colmenarejo, G, Alvarez-Pedraglio A., & Lavandera, J. L. (2009). Cheminformatic models to predict binding affinities to human serum albumin. Journal of Medicinal Chemistry, 44, 4370–4378.
   Google Scholar
• Cronet, P, Petersen, J. F. W., Folmer, R, Blomberg, N, Sjöblom, K, Karlsson, U, Lindstedt, E. L., & Bamberg, K (2001). Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure, 9, 699–706.10.1016/S0969-2126(01)00634-7
   PubMed Web of Science ®Google Scholar
• Desvergne, B., & Wahli, W. (1999). Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocrine Reviews, 20, 649–668.
   PubMed Web of Science ®Google Scholar
• Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992). Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 68, 879–887.10.1016/0092-8674(92)90031-7
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43, 3867–3877.10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T. … Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47, 1739–1749.
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., & Mainz, D. T. (2015). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49, 6177–6196.
   Google Scholar
• Fruchart, J. C. (2002). Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolism. American Journal of Cardiology, 88, 24–29.
   Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47, 1750–1759.10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Hasan, M. A., Mazumder, M. H. H, Chowdhury, A. S, Datta, A., & Khan, M. A. (2015). Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment. Source Code for Biology and Medicine, 10, 1–14.
   PubMed Web of Science ®Google Scholar
• Hayes, J. M., Skamnaki, V. T., Archontis, G., Lamprakis, C., Sarrou, J., Bischler, N. … Oikonomakos, N. G. (2011). Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: The role of water molecules examined. Proteins: Structure, Function, and Bioinformatics, 79, 703–719. doi:10.1002/prot.22890
   PubMed Web of Science ®Google Scholar
• Issemann, I., & Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645–650.10.1038/347645a0
   PubMed Web of Science ®Google Scholar
• Jakubík, J, El-Fakahany, E. E., & Doležal, V. (2015). Towards predictive docking at aminergic G-protein coupled receptors. Journal of Molecular Modeling, 21, 1–18.
   PubMed Web of Science ®Google Scholar
• Jang, J. Y., Koh, M., Bae, H., An, D. R., Im, H. N., Kim, H. S., … Suh, S. W. (2017). Structural basis for differential activities of enantiomeric PPARgamma agonists: Binding of S35 to the alternate site. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1865, 674–681. doi:10.1016/j.bbapap.2017.03.008
   PubMed Web of Science ®Google Scholar
• Kallubai, M., Amineni, U., Mallavarapu, M., & Kadiyala, V. (2015). In silico approach to support that p-nitrophenol monooxygenase from Arthrobacter sp. strain JS443 catalyzes the initial two sequential monooxygenations. Interdisciplinary Sciences, 7, 157–167. doi: 10.1007/s12539-015-0018-x
   PubMed Web of Science ®Google Scholar
• Katari, S. K., Natarajan, P., Swargam, S., Kanipakam, H., Pasala, C., & Umamaheswari, A. (2016). Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations. Journal of Receptors and Signal Transduction, 36, 558–571. doi:10.3109/10799893.2016.1141955
   PubMed Web of Science ®Google Scholar
• Ke, Y. Y., Singh, V. K., Coumar, M. S., Hsu, Y. C., Wang, W. C., Song, J. S., … Hsu, J. T. A. (2014). Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification. Scientific Reports, 5, 1–12.
   Web of Science ®Google Scholar
• Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J. P. (1999). Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharmaceutical Research, 16, 1514–1519.10.1023/A:1015040217741
   PubMed Web of Science ®Google Scholar
• Lefebvre, P., Chinetti, G., Fruchart, J. C., & Staels, B. (2006). Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. Journal of Clinical Investigation, 116, 571–580.10.1172/JCI27989
   PubMed Web of Science ®Google Scholar
• van Marrewijk, L. M., Polyak, S. W., Hijnen, M., Kuruvilla, D., Chang, M. R., Shin, Y., … Bruning, J. B. (2016). SR2067 reveals a unique kinetic and structural signature for PPARgamma partial agonism. ACS Chemical Biology, 11, 273–283. doi:10.1021/acschembio.5b00580
   PubMed Web of Science ®Google Scholar
• Murray, C. W., Auton, T. R., & Eldridge, M. D. (1998). Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model. Journal of Computer-Aided Molecular Design, 12, 503–519.10.1023/A:1008040323669
   PubMed Web of Science ®Google Scholar
• Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., & Milburn, M. V. (1998). Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature, 395, 137–143.
   PubMed Web of Science ®Google Scholar
• Priyadarshini, V., Pradhan, D., Munikumar, M., Swargam, S., Umamaheswari, A., & Rajasekhar, D. (2014). Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. Journal of Biomolecular Structure & Dynamics, 32, 876–889.10.1080/07391102.2013.795871
   PubMed Web of Science ®Google Scholar
• Rosen, E. D., & Spiegelman, B. M. (2001). PPARgamma : A nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry, 276, 37731–37734. doi:10.1074/jbc.R100034200
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27, 221–234.10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Scott, C. L. (2003). Diagnosis, prevention, and intervention for the metabolic syndrome. The American Journal of Cardiology, 92, 35–42.10.1016/S0002-9149(03)00507-1
   Web of Science ®Google Scholar
• Shu, M., Lin, Z., Zhang, Y., Wu, Y., Mei, H., & Jiang, Y. (2011). Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus. Journal of Molecular Modeling, 17, 587–592.10.1007/s00894-010-0757-x
   PubMed Web of Science ®Google Scholar
• Singh, K. D., Kirubakaran, P., Nagarajan, S., Sakkiah, S., Muthusamy, K., Velmurgan, D., & Jeyakanthan, J. (2012). Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease. Journal of Molecular Modeling, 18, 39–51. doi:10.1007/s00894-011-1018-3
   PubMed Web of Science ®Google Scholar
• Singh, J., Kumar, M., Mansuri, R., Sahoo, G., & Deep, A. (2016). Inhibitor designing, virtual screening, and docking studies for methyltransferase: A potential target against dengue virus. Journal of Pharmacy And Bioallied Sciences, 8, 188–194. doi:10.4103/0975-7406.171682
   PubMed Web of Science ®Google Scholar
• Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J. C. (1998). Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation, 98, 2088–2093.10.1161/01.CIR.98.19.2088
   PubMed Web of Science ®Google Scholar
• Susnow, R. G. Dixon, S. L. (2002). Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition. Journal of Chemical Information & Computer Sciences, 43, 1308–1315.
   Google Scholar
• Thangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011). dynamic structure-based pharmacophore model development: A new and effective addition in the histone deacetylase 8 (HDAC8) inhibitor discovery. International Journal of Molecular Sciences, 12, 9440–9462.10.3390/ijms12129440
   PubMed Web of Science ®Google Scholar
• Van de Waterbeemd, H, Camenisch, G, Folkers, G, Chretien, J. R., & Raevsky, O. A. (1998). Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-Bonding descriptors. Journal of Drug Targeting, 6, 151–165.
   PubMed Web of Science ®Google Scholar
• Wahli, W., Braissant, O., & Desvergne, B. (1995). Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more…. Chemistry & Biology, 2, 261–266.10.1016/1074-5521(95)90045-4
   PubMed Web of Science ®Google Scholar
• Wang, X. J., Zhang, J., Wang, S. Q., Xu, W. R., Cheng, X. C., & Wang, R. L. (2014). Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone. Drug Design Development & Therapy, 2014, 2255–2262.
   Google Scholar
• Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000). The PPARs: From orphan receptors to drug discovery. Journal of Medicinal Chemistry, 43, 527–550.10.1021/jm990554 g
   PubMed Web of Science ®Google Scholar
• Xia, X., Maliski, E. G., Gallant, P., & Rogers, D. (2004). Classification of kinase inhibitors using a bayesian model. Journal of Medicinal Chemistry, 47, 4463–4470.10.1021/jm0303195
   PubMed Web of Science ®Google Scholar
• Xu, C., Wang, L. L., Liu, H. Y., Ruan, C. M., Zhou, X. B., Cao, Y. L., & Li, S. (2006). A novel dual peroxisome proliferator-activated receptors alpha and gamma agonist with beneficial effects on insulin resistance and lipid metabolism. Biotechnology Letters, 28, 863–868. doi:10.1007/s10529-006-9013-y
   PubMed Web of Science ®Google Scholar
• Yadav, R. K., & Yadava, U. (2016). Molecular dynamics simulation of hydrated d(CGGGTACCCG)as a four-way DNA holliday junction and comparison with the crystallographic structure. Molecular Simulation, 42, 25–30.10.1080/08927022.2015.1007052
   Web of Science ®Google Scholar
• Yadava, U., Gupta, H., & Roychoudhury, M. (2015). Stabilization of microtubules by taxane diterpenoids: Insight from docking and MD simulations. Journal of Biological Physics, 41, 1–17.
   PubMed Web of Science ®Google Scholar
• Yadava, U., Shukla, B. K., Roychoudhury, M., & Kumar, D. (2015). Pyrazolo[3,4-d]pyrimidines as novel inhibitors of O-acetyl-l-serine sulfhydrylase of Entamoeba histolytica: An in silico study. Journal of Molecular Modeling, 21, 105. doi:10.1007/s00894-015-2631-3
   PubMed Web of Science ®Google Scholar